Meet the 2024 Graduate Research Fellows – Go Health Pro

Meet the 2024 Graduate Research Fellows – Go Health Pro

Each year, Florida Sea Grant selects exceptional graduate students to award up to $25,000 in funds for their research in coastal and ocean science. In 2024, seven students across Florida were selected to be a part of this prestigious cohort of Graduate Fellows.  Christopher Crowder Christopher Crowder is a Greenwood, Indiana, native and a PhD … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available Liquidity – Go Health Pro

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On December 9, 2024, CytoSorbents (NASDAQ:CTSO) announced a shareholder friendly anticipated Rights Offering which is expected to substantially increase its liquidity position. Investors who own or have bought CTSO stock by the close of trading on Friday, December 13, 2024 will be considered stockholders … Read more

Zacks Small Cap Research – NVX: Positive Takeaways From Analyst Day Include Company’s Successful Attainment of 2024 Key Objectives – Go Health Pro

Zacks Small Cap Research – NVX: Positive Takeaways From Analyst Day Include Company’s Successful Attainment of 2024 Key Objectives – Go Health Pro

By M. Marin NASDAQ:NVX READ THE FULL NVX RESEARCH REPORT NVX has successfully attained four key objectives, including securing upfront demand & funding Novonix (NASDAQ:NVX) hosted an Investor Day last week that we attended virtually. As the company contributes to the development of a North American-based supply chain to support the battery and clean energy … Read more

Zacks Small Cap Research – MNOV: Encouraging Interim Analysis for Phase 2b/3 ALS Trial… – Go Health Pro

By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Encouraging Interim Results from Phase 2b/3 COMBAT-ALS Trial On December 5, 2024, MediciNova, Inc. (NASDAQ:MNOV) announced a poster presentation at the 35th International Symposium on ALS/MND would feature a study update and interim analysis results from the ongoing Phase 2b/3 COMBAT-ALS trial … Read more

Zacks Small Cap Research – SWP.TO: Industry Outlook Shows Expected Catalysts for Swiss Water Growth Continuing – Go Health Pro

Zacks Small Cap Research – SWP.TO: Industry Outlook Shows Expected Catalysts for Swiss Water Growth Continuing – Go Health Pro

By M. Marin OTC:SWSSF | TSX:SWP.TO READ THE FULL SWP.TO RESEARCH REPORT Rising consumption of ‘decaf’ & specialty coffees important are growth drivers that are expected to continue… British Columbia-based Swiss Water Decaffeinated Coffee Inc. (OTC:SWSSF) (TSX:SWP.TO) is a leading specialty coffee company and premium green coffee decaffeinator focused on producing chemical-free decaffeinated coffee. The … Read more

x